CAS: 180683-37-8 - (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide hydrate (non-preferred name)
Formula:C36H49N5O5
InChI:InChI=1/C36H47N5O4.H2O/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43;/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45);1H2/t28-,29+,31+,32-,33+;/m1./s1
- Synonyms:
- (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide hydrate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Indinavir System Suitability REF: 45-1339189CAS: 180683-37-8 | - - - | 697.00 € | Thu 23 May 24 | |
Indinavir REF: 45-1339178CAS: 180683-37-8 | - - - | 408.00 € | Thu 23 May 24 | |
Indinavir monohydrate REF: 3D-FI176213CAS: 180683-37-8 | Min. 95% | To inquire | Fri 05 Jul 24 |
Indinavir System Suitability
CAS:180683-37-8
Drugs containing a pyrimidine ring (whether or not hydr
Formula:
C36H47N5O4·H2O
Color and Shape:
Powder
Molecular weight:
631.81
Estimated delivery in United States, on Thursday 23 May 2024
Indinavir
CAS:180683-37-8
Drugs containing a pyrimidine ring (whether or not hydr
Formula:
C36H47N5O4·H2O
Color and Shape:
Powder
Molecular weight:
631.81
Estimated delivery in United States, on Thursday 23 May 2024
Indinavir monohydrate
CAS:180683-37-8
Indinavir is a protease inhibitor used to treat HIV infection. It binds to the active …
Purity:
Min. 95%
Ref: 3D-FI176213
100mg | To inquire |
Estimated delivery in United States, on Friday 5 Jul 2024